PSI CRO is expanding into South Africa, establishing an office in Pretoria. PSI will expand its access to all African countries from this location. PSI’s current experience in South Africa covers oncology, CNS, urology, diabetes and other therapeutic areas.
 
South Africa is a multi-cultural nation with a population of approximately 50 million people, and has a long history of conducting clinical trials. The region has a strong infrastructure to support all activities including regulatory oversight and experienced researchers. Additionally, data generated from South African trials is accepted internationally.